Nathaniel Calloway

Insider Reports History

Entity
Individual
Location
C/O Anebulo Pharmaceuticals, Inc., 1415 Ranch Road 620 South, Suite 201, Lakeway, TX
Signature
/s/ Daniel George, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nathaniel Calloway:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LIFECORE BIOMEDICAL, INC. \DE\ Director Common Stock 58.1K $406K $7.00 Jul 8, 2024 Direct
LIFECORE BIOMEDICAL, INC. \DE\ Director Restricted Stock Unit 0 $0 $7.00 Feb 1, 2024 Direct
Anebulo Pharmaceuticals, Inc. Director Stock Option (right to buy) 3.31K Apr 4, 2025 Direct

Insider Reports Filed by Nathaniel Calloway

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ANEB Anebulo Pharmaceuticals, Inc. Apr 4, 2025 2 $0 4 Apr 7, 2025 Director
LFCR LIFECORE BIOMEDICAL, INC. \DE\ Jul 8, 2024 1 $0 4 Jul 10, 2024 Director
ANEB Anebulo Pharmaceuticals, Inc. Jun 13, 2024 2 $0 4 Jun 17, 2024 Director
LFCR LIFECORE BIOMEDICAL, INC. \DE\ Feb 1, 2024 2 $0 4 Feb 2, 2024 Director
LFCR LIFECORE BIOMEDICAL, INC. \DE\ Jan 9, 2024 2 $0 4 Jan 10, 2024 Director
LFCR LIFECORE BIOMEDICAL, INC. \DE\ Jun 1, 2023 1 $0 4 Jun 5, 2023 Director
LFCR LIFECORE BIOMEDICAL, INC. \DE\ Feb 1, 2023 1 $0 4 Feb 2, 2023 Director
LFCR LIFECORE BIOMEDICAL, INC. \DE\ Jan 9, 2023 1 $0 4 Jan 11, 2023 Director
LFCR LIFECORE BIOMEDICAL, INC. \DE\ Jan 9, 2023 0 $0 3 Jan 11, 2023 Director
ANEB Anebulo Pharmaceuticals, Inc. Nov 1, 2022 1 $0 4 Nov 2, 2022 Director
ANEB Anebulo Pharmaceuticals, Inc. Oct 28, 2022 0 $0 3 Nov 2, 2022 Director